COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes
D Focosi, M Franchini, L Pirofski… - Clinical microbiology …, 2022 - Am Soc Microbiol
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …
available as soon as there are survivors. The COVID-19 pandemic represented the first …
Antibody and B cell responses to SARS-CoV-2 infection and vaccination: the end of the beginning
As the COVID-19 pandemic has evolved during the past years, interactions between human
immune systems, rapidly mutating and selected SARS-CoV-2 viral variants, and effective …
immune systems, rapidly mutating and selected SARS-CoV-2 viral variants, and effective …
Guidance on the use of convalescent plasma to treat immunocompromised patients with coronavirus disease 2019
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is a safe and
effective treatment for COVID-19 in immunocompromised (IC) patients. IC patients have a …
effective treatment for COVID-19 in immunocompromised (IC) patients. IC patients have a …
Overview of autoantibodies in COVID‐19 convalescents
K Dobrowolska, D Zarębska‐Michaluk… - Journal of medical …, 2023 - Wiley Online Library
Accumulating evidence shows that SARS‐CoV‐2 can potentially trigger autoimmune
processes, which can be responsible for the long‐term consequences of COVID‐19 …
processes, which can be responsible for the long‐term consequences of COVID‐19 …
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with convalescent plasma: a systematic review and meta-analysis
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19 …
mortality and the differences between subgroups in hospitalized patients with COVID-19 …
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
In the Spring of 2020, the United States of America (USA) deployed COVID-19 convalescent
plasma (CCP) to treat hospitalized patients. Over 500,000 patients were treated with CCP …
plasma (CCP) to treat hospitalized patients. Over 500,000 patients were treated with CCP …
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
BACKGROUND Neutralizing antibodies are considered a key correlate of protection by
current SARS-CoV-2 vaccines. The manner in which human infections respond to …
current SARS-CoV-2 vaccines. The manner in which human infections respond to …
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
A Casadevall, MJ Joyner, LA Pirofski… - Expert review of …, 2023 - Taylor & Francis
Introduction When the COVID-19 pandemic struck no specific therapies were available and
many turned to COVID-19 convalescent plasma (CCP), a form of antibody therapy. The …
many turned to COVID-19 convalescent plasma (CCP), a form of antibody therapy. The …
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
JG Ripoll, EK Gorman, JE Juskewitch… - Blood …, 2022 - ashpublications.org
Although severe coronavirus disease 2019 (COVID-19) and death from COVID-19 are
generally preventable in immunocompetent people in areas of the world with sufficient …
generally preventable in immunocompetent people in areas of the world with sufficient …
Impact of the COVID‐19 pandemic on blood donation and transfusions in the United States in 2020
SV Basavaraju, RJ Free, JL Chavez Ortiz… - …, 2023 - Wiley Online Library
Introduction Reports have suggested the COVID‐19 pandemic resulted in blood donation
shortages and adverse impacts on the blood supply. Using data from the National Blood …
shortages and adverse impacts on the blood supply. Using data from the National Blood …